Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| DM-CRESTOR-0003 | Other Identifier | AstraZeneca |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the effectiveness of Rosuvastatin versus Ezetimibe/Simvastatin in dyslipidemic patients treated for at least 8 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dislipidemic Population | People with high levels of total cholesterol, LDL, C-HDL and triglycerides |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The percentage of the patients that achieve the goal proposed for NCEP ATP III (2001 y 2004) will be assessed, to C-LDL in patients treated with Rosuvastatin or Ezetimibe/Simvastatin at least for 8 weeks. | Data will be collected using CRFs after complete at least 15 patients over a 24 week period. |
| Measure | Description | Time Frame |
|---|---|---|
| The percentage of LDL-C reduction according to baseline levels in patients treated wuth Rosuvastatin or Ezetimibe/Simvastatin for at least 8 weeks. | Data will be collected using CRFs after complete at least 15 patients over a 24 week period. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Care clinic private practice
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ana Polanco, MD | AstraZeneca | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Guadalajara | Jalisco | Mexico | |||
| Research Site |
Not provided
| ID | Term |
|---|---|
| D050171 | Dyslipidemias |
| D006937 | Hypercholesterolemia |
| ID | Term |
|---|---|
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D006949 | Hyperlipidemias |
Not provided
Not provided
Not provided
Not provided
Not provided
| Mexico City |
| Mexico City |
| Mexico |
| Research Site | Cuernavaca | Morelos | Mexico |
| Research Site | Monterrey | Nuevo León | Mexico |
| Research Site | Puebla City | Puebla | Mexico |
| Research Site | San Luis Potosí City | San Luis Potosí | Mexico |
| Research Site | Veracruz | Xalapa | Mexico |
| Research Site | Mérida | Yucatán | Mexico |
| Research Site | Durango | Mexico |